Xylem (XYL) Stock Forecast & Price Target

$125.69 -1.32 (-1.04%)

Closing price 05/21/2025 03:59 PM Eastern

Extended Trading

$125.63 -0.06 (-0.05%)

As of 05/21/2025 04:20 PM Eastern

Xylem - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 10 Analyst Ratings

Sell
0

Hold
3

Buy
7

Based on 10 Wall Street analysts who have issued ratings for Xylem in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 10 analysts, 3 have given a hold rating, and 7 have given a buy rating for XYL.

Consensus Price Target

$146.88
16.86% Upside

According to the 10 analysts' twelve-month price targets for Xylem, the average price target is $146.88. The highest price target for XYL is $165.00, while the lowest price target for XYL is $125.00. The average price target represents a forecasted upside of 16.86% from the current price of $125.69.

Get the Latest News and Ratings for XYL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Xylem and its competitors.

XYL Analyst Ratings Over Time

Type	Current Forecast 5/22/24 to 5/22/25	1 Month Ago 4/22/24 to 4/22/25	3 Months Ago 2/22/24 to 2/21/25	1 Year Ago 5/23/23 to 5/22/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	7 Buy rating(s)	7 Buy rating(s)	7 Buy rating(s)	8 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$146.88	$147.33	$149.90	$140.70
Forecasted Upside	16.86% Upside	32.13% Upside	17.74% Upside	-3.10% Downside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

XYL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

XYL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Xylem Stock vs. The Competition

Type	Xylem	Business Services Companies	S&P 500
Consensus Rating Score	2.70	2.71	2.54
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	16.86% Upside	2,172.05% Upside	15.78% Upside
News Sentiment Rating	Positive News See Recent XYL News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
5/15/2025	Raymond James 4 of 5 stars	B. Zolper Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
4/30/2025	Royal Bank of Canada 3 of 5 stars	Deane Dray Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Outperform ➝ Outperform	$143.00 ➝ $147.00	+23.38%
4/30/2025	Stifel Nicolaus 4 of 5 stars	Nathan Jones Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$140.00 ➝ $141.00	+18.43%
4/30/2025	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Michael Halloran Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Outperform ➝ Outperform	$149.00 ➝ $146.00	+23.38%
4/14/2025	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Kaplowitz Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$152.00 ➝ $134.00	+22.03%
12/12/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Hewitt Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Peer Perform
11/6/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Giordano Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Hold ➝ Hold	$138.00 ➝ $125.00	+1.12%
8/13/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Karas Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$165.00	+29.41%
5/31/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$147.00 ➝ $152.00	+9.71%
5/29/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Eade Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$146.00 ➝ $165.00	+19.75%
Get the Latest News and Ratings for XYL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Xylem and its competitors with MarketBeat's FREE daily newsletter.
5/3/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$110.00 ➝ $135.00	-0.73%
3/12/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$150.00	+18.88%
11/21/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$104.00 ➝ $120.00	+19.74%
10/2/2023	Melius Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$122.00	+33.46%
8/29/2023	Seaport Res Ptn Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Graham Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral
6/29/2023	888 Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Initiates

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 05:30 AM ET.

Should I Buy Xylem Stock? XYL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, May 14, 2025. Please send any questions or comments about these Xylem pros and cons to contact@marketbeat.com.

Xylem
Bull Case

Here are some ways that investors could benefit from investing in Xylem Inc.:

The current stock price is around $117, which is relatively stable compared to its one-year high of $146.08, indicating potential for growth.
Xylem Inc. reported a strong quarterly earnings result, with earnings per share (EPS) of $1.03, exceeding analysts' expectations, which reflects robust financial health.
The company has a low debt-to-equity ratio of 0.19, suggesting that it is not heavily reliant on debt for financing, which can be a sign of financial stability.
With a market capitalization of approximately $30 billion, Xylem Inc. is positioned as a significant player in the industrial products sector, which can attract institutional investors.
The firm has shown a year-over-year revenue increase of 1.8%, indicating a positive growth trend in its operations.

Xylem
Bear Case

Investors should be bearish about investing in Xylem Inc. for these reasons:

The price-to-earnings (P/E) ratio is around 34.26, which may indicate that the stock is overvalued compared to its earnings, potentially leading to a price correction.
Despite a positive revenue growth, the net margin of 10.40% suggests that profitability could be a concern, as it may limit the company's ability to reinvest in growth opportunities.
The stock has experienced fluctuations, with a significant difference between its one-year low and high, which may indicate volatility and risk for investors.
Analysts predict an EPS of 4.65 for the current year, which may not be sufficient to justify the current stock price, raising concerns about future performance.
The beta of 1.10 indicates that the stock is slightly more volatile than the market, which could lead to higher risk for investors during market downturns.

XYL Forecast - Frequently Asked Questions

: According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for Xylem is $146.88, with a high forecast of $165.00 and a low forecast of $125.00.
: 10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Xylem in the last twelve months. There are currently 3 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" XYL shares.
: According to analysts, Xylem's stock has a predicted upside of 16.86% based on their 12-month stock forecasts.
: Over the previous 90 days, Xylem's stock had 1 upgrade by analysts.
: Xylem has been rated by research analysts at Citigroup, Raymond James, Robert W. Baird, Royal Bank of Canada, and Stifel Nicolaus in the past 90 days.
: Analysts like Xylem less than other "business services" companies. The consensus rating score for Xylem is 2.70 while the average consensus rating score for "business services" companies is 2.71. Learn more on how XYL compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:XYL) was last updated on 5/22/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Xylem (XYL) Stock Forecast & Price Target